Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.
about
DNA methylation changes in epithelial ovarian cancer histotypes.Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerKRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinomaDifferential analysis of ovarian and endometrial cancers identifies a methylator phenotypeBRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsIntratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasGene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.The new face of ovarian cancer modeling: better prospects for detection and treatment.The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer.CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesisGenome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.The duplicitous origin of ovarian cancer.Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelConstitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potentialGenome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylationTargeting the epigenome in ovarian cancer.DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression.Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma.The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers.One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
P2860
Q27690722-30379AD3-7BAB-4559-AC98-C5D779D4DB9DQ28238067-A1BF74D5-F214-4711-8A92-88A29506CC06Q33893010-A419F734-C57B-4887-A22F-F7207E05F0B3Q34189765-A1D8131D-6B36-4C3B-8824-BFFA2FF07CB7Q35041937-2013F056-2333-410B-92AF-A8CD2A79BBD3Q35060446-61A1C24C-5667-454B-A078-11A31EB982F9Q35137818-C6E70A28-97B8-4457-8A8F-5F02B5461F26Q35140600-5771BE08-D81C-4DCF-8F2D-F4ED52619C9BQ35209365-D77D77DD-28E4-4C31-97DF-699B3B6ADE49Q35507860-A74D27B5-A350-4AA3-89A3-C4DFBBB3259BQ36005081-EABD0A21-E88A-40B0-AB99-58E7493EC4C4Q36022324-97E1DB83-3898-4D12-A2C3-716FA8DB7757Q36305814-C36E626B-7892-4631-A4B4-795660768344Q36402765-E8558B61-299B-47EA-B0F7-39053EDD43FFQ36919484-83318E0D-DED7-45B0-8869-4B154C12E02BQ36975149-83B0C83F-D841-45A8-BAF6-F46EBDB52E3AQ36989636-68CD2443-552A-4164-AD4F-5054C9AA14D0Q37353774-417BDA6C-B54D-449B-ADAC-97ADC5D5037DQ37492937-8FEB73BF-57E2-4A5C-8E63-E9D57659FC5BQ37610042-4B22FF8F-7942-4285-AC39-CA9E39D9B582Q37984122-055A446D-BAA7-414C-8854-D505F172B364Q38790328-54E4BA61-754A-45A8-A563-A96021C4E92AQ40602149-598A3C73-750B-4CFF-8CE5-3C94E994C768Q42961773-6A4A83EB-3614-4CEE-B392-8054AD0CB0EDQ54204521-A762659A-458F-4FB8-8573-97F04923C811Q55629563-CDE21B1F-2590-4205-B1F7-3202F04D598BQ59134002-72A1AF4F-F659-4FE3-A119-7921D7A862E0
P2860
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@ast
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@en
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@nl
type
label
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@ast
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@en
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@nl
prefLabel
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@ast
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@en
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@nl
P2093
P2860
P1476
Distinct DNA methylation profi ...... ons in ovarian carcinogenesis.
@en
P2093
Ben Davidson
Chen C Wang
Ie-Ming Shih
Jianhua Xuan
Jinghua Gu
Leslie Cope
Robert J Kurman
Tian-Li Wang
P2860
P304
P356
10.1016/J.AJOG.2010.08.003
P407
P577
2010-10-20T00:00:00Z